Sartans Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Sartans Industry Market Size Be by 2025?
The consistent expansion of the sartans market has been evident in the past years. The market value is predicted to escalate from $21.36 billion in 2024 to $22.18 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.8%. Several factors are responsible for the growth experienced in the historic period. These include the increasing preference for sedentary lifestyles, growing obesity rates, a heightened understanding of cardiovascular diseases, increased expenditure in healthcare, and a burgeoning demand for generic antihypertensive medications.

What's the Long-Term Growth Forecast for the Sartans Market Size Through 2029?
In the forthcoming years, the sartans market size is forecasted to experience continual growth. Forecasted to reach a value of "$26.07 billion in 2029", the compound annual growth rate will be 4.1%. The anticipated growth during the forecast period is attributed to the heightened emphasis on combination treatments, accelerating investments in pharmaceutical research and development, burgeoning demand from developing markets, development in healthcare infrastructure, and an increase in lifestyle-associated disorders. Within this forecast period, some key trends are expected to emerge, including advancements in drug delivery technologies, progress in the manufacturing processes of Active Pharmaceutical Ingredients (APIs), the making of fixed-dose combination drugs, advancements in personalized treatment for hypertension, and the creation of new sartan derivatives.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

What Are the Key Growth Drivers Fueling the Sartans Market Expansion?
The escalation of hypertension occurrences is presumed to thrust the future expansion of the sartans market. Hypertension, characterized by elevated blood pressure that won't dip over time, could augment the risk of cardiac disease, strokes, and other significant health issues. The surging frequency of hypertension is associated with a diet heavy in salt and processed foods, contributing to retaining fluid and straining the heart. Sartans are used to manage hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This results in the relaxation and dilation of the vessels, reducing blood pressure and alleviating the stress on the heart. For instance, in 2024, the American Heart Association-a nonprofit organization based in the US-reported that 131,454 deaths in 2022 were mainly attributed to elevated blood pressure, showing an increase from the 124,508 deaths logged in 2021. Hence, the climbing prevalence of hypertension is stimulating the growth of the sartans market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Sartans Market?
Key players in the sartans market are directing their efforts towards the innovation of advanced offerings like tablet-form sartans to increase the effectiveness of treatment and patient compliance. These tablet-form sartans are taken orally and comprise of sartan drugs that hinder the impact of angiotensin II, leading to blood vessel relaxation and blood pressure reduction. For instance, Zydus Lifesciences, a pharmaceutical firm based in India, obtained approval from the US Food and Drug Administration (FDA) in July 2024 for its Valsartan Tablets USP (40 mg, 80 mg). The tablets, which are sold under the Diovan brand name, are utilized to manage hypertension and heart failure, enhance survival chances after a heart attack in adults, and are also appropriate for children over one year old.

How Is the Sartans Market Segmented?
The sartans market covered in this report is segmented -

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp

Which Companies Are Leading the Charge in Sartans Market Innovation?
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Which Regions Are Leading the Global Sartans Market in Revenue?
North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24393

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.